CADScor®System NOW AVAILABLE IN THE US
Acarix USA, Inc brings innovative AI-based technology to assess patients with chronic chest-pain to help rule out Coronary Artery Disease (CAD) in less than 10 minutes with 96% confidence.
With FDA DeNovo clearance and CPTIII listing, CADScor®System is now launching in the United States.
COME VISIT US AT FUTURE HUB BOOTH FH11.
ACC.22 Learning Pathways? (select all that apply) Ischemic Heart Disease